Prevention of Drug Deaths

Debate between Grahame Morris and Caroline Johnson
Thursday 27th March 2025

(4 days, 22 hours ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Caroline Johnson Portrait Dr Caroline Johnson (Sleaford and North Hykeham) (Con)
- Hansard - - - Excerpts

It is a pleasure and a privilege to serve under your chairmanship, Dr Murrison. I pass my condolences to the family, friends and colleagues of Christina McKelvie. I know she meant a lot to many of the people in this room.

Members on both sides will recognise the vital importance of the topic before us today in relation to our health and wellbeing as a nation. Let us be clear: deaths across the UK remain too high and in many cases, trends are moving in the wrong direction. Therefore, I congratulate the hon. Member for Strangford (Jim Shannon) on bringing this important debate so we can talk about it further.

The Office for National Statistics notes that 5,448 deaths related to drug poisoning were registered in 2023 across England and Wales—93 deaths per million people—but those headline figures tell only part of the story, of course, because behind each one is a tragedy for a family.

There is a significant gender imbalance in drug deaths. Of the nearly 5,500 deaths in England and Wales, 3,645 were men and 1,803 were women. There is also an imbalance among the English regions, as the hon. Member for Easington (Grahame Morris) said. The north-east of England remains the region with the highest rate of deaths related to drugs—London has a third of that rate. What steps are the Government taking to understand the epidemiology of drug use? How are they using that information to develop policies to reduce drug use and drug deaths?

Another key demographic trend relates to age. ONS survey data for 2024 shows that 16.5% of people aged 16 to 24 reported using at least one drug in the year to March 2024, and approximately 150,000 in the same age bracket considered themselves frequent drug users. Education will clearly be a vital element of any strategy designed to prevent people from becoming addicted to drugs and going on to cause harm to themselves and their community. Education needs to be clear about the damage that drug consumption does to individuals and society, through antisocial behaviour, environmental pollution and serious organised crime committed by gangs. What steps are the Government taking to ensure schools and colleges provide effective, targeted education to young people? What conversations has the Minister had with education Ministers about that? What are they doing to extend that education to those who are lost to the system—those who are not attending school and are therefore at greater risk of developing addictions and being exploited?

As has been mentioned, we also need to understand the changing patterns of use around particular drugs. Fashions change, and we must confront today’s challenges proactively, rather than yesterday’s ones reactively. Deaths involving cocaine rose by 30% in a single year in 2023, and synthetic opioids such as fentanyl pose another emerging risk. We know that such substances have caused catastrophic harm in other countries, where they are already a fixture of the drug supply chain. What lessons have the Minister and the Government learned from other countries’ experiences with synthetic opioids? What steps are they taking to ensure the risk does not develop into the sort of crisis that we have seen in other countries?

Behind the statistics, there are people who use drugs and people in our communities who suffer the impacts. We need to look at both, and at the patterns of drug use. Inner-city areas suffering multiple forms of deprivation may face greater problems with substances such as heroin. As Members said, the Scottish Government recently opened the UK’s first drug consumption room in Glasgow, with the intention to address that kind of drug use. Long-term evidence about the effectiveness of such rooms is not clear at this stage, so I am pleased that the UK Government’s position is not to implement the strategy more widely. Treatment must be evidence-based, compassionate and effective, and it must not be done in a way that undermines the law, risking more people thinking that drugs are safe or not risky.

Grahame Morris Portrait Grahame Morris
- Hansard - -

That is the status quo, but should we not be challenging that and looking at the evidence from, for example, prisons? One might assume that someone who is incarcerated due to crimes resulting from drug addiction would receive treatment in prison and rehabilitated, but in practice they are actually worse when they come out, and Buvidal, a long-lasting drug that could be very effective, is not readily available. Does the shadow Minister have any views on that?

Caroline Johnson Portrait Dr Johnson
- Hansard - - - Excerpts

I completely agree that we need evidence-based policy, and that, in whatever policy area we are looking at, we should challenge and probe policies to ensure we are doing things in the right way. Drugs should not be available in our prisons. People should receive treatment if they have gone into prison due to a drug-related offence, or if it is a non-drug-related offence but they are a drug user, but they should not have access to drugs. Prisons are controlled environments, so we should be able to prevent that. The Minister might be able to update us on what the Government will do to reduce the amount of drugs available in prisons.

We must also look at the effects on the local area around drug consumption rooms. What effect does allowing people to use drugs have on the numbers for violent gang crime, acquisitive crime and drug use? The evidence needs to be looked at closely.

There are other contexts in which drug use causes problems. Media coverage in recent years has highlighted the problem of so-called middle-class drug taking in family homes or at dinner parties. That is a different pattern of use, with different problems, and may risk setting precedents and norms, particularly for young children who may witness it, that might have damaging effects in years to come. Such drug use may be occurring in middle-class homes, but it still fuels organised crime and violence elsewhere. What are the Government doing to address the nuances in different habits and social contexts of drug use, and how do those figure in policy development?

We should also think about the prevalence of drug use in contexts such as workplaces. Some workplaces, such as the police, use intermittent drug testing. Police can use stop and search powers to investigate misuse, but there are other opportunities to interrupt harmful behaviour. What is the Government’s position on random drug testing in employment settings?

Regarding people in communities blighted by the effects of drug use, it is important to enforce the law as it is. In 2021, only 20% of drug-related offences recorded in Home Office data resulted in the user being charged or summonsed, and 34% of those offences resulted in an out of court or informal settlement. Some today have seemed to suggest that treatment and law enforcement are an either/or, but both are very important. Minimising the criminal offence could increase drug use, derisk the first trying of drugs among young people, embolden drug dealers and further harm neighbours who suffer drug-related harm. According to ONS data for 2024, 39.2% of respondents to the crime survey for England and Wales said it would be very or fairly easy to obtain illegal drugs within 24 hours. How do the Government intend to reduce the availability of illegal substances?

The last Government implemented a 10-year drug strategy following the publication of the independent review of drugs undertaken by Dame Carol Black in 2020, and they committed an additional £523 million up to 2025 to improve the capacity and quality of drug and alcohol treatment services. This strategy set out aspirations to prevent nearly 1,000 deaths and deliver a phased expansion of treatment capacity, with at least 54,500 new high-quality treatment places for sufferers of addiction.

The present Government need to set out a coherent and viable plan for tackling the problems that the previous Government had begun to address. On 26 November last year, Parliamentary Under-Secretary of State Baroness Merron noted that the Government

“continue to fund research into wearable technology, virtual reality and artificial intelligence, all in a bid to support people with drug addictions.”—[Official Report, House of Lords, 26 November 2024; Vol. 841, c. 594.]

That cost £12 million in the period from the election to 26 November. Will the Minister update the House on the evidence for the effectiveness of those measures? How do they intend to measure the value of the outcomes of that £12 million investment, and does she have any results on how effective they were?

Drug use continues to cause substantial harm to individuals and communities across the UK. The Government must commit to evidence-based interventions and plan the UK’s drugs strategy in a manner that limits the opportunities for individuals to distribute or consume drugs, reduces the likelihood that young people will develop an addiction, and prevents communities from suffering the impact of ineffective policing and sanctions.